IN BRIEF: Seed Innovations investee signs A$2.0 million two-year deal

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Seed Innovations Ltd - Guernsey-based wellness and life sciences company - Says investee Little Green Pharma Ltd has signed a two-year medicinal cannabis supply deal with Ilios Sante GmbH, worth A$2.0 million. Ilios Sante is a German-based licensed pharmaceutical wholesaler and subsidiary of the Bloomwell Group, a European medical cannabis healthcare company. Seed says the deal involves a non-exclusive LGP white label medicinal cannabis product.

Seed Vice President Alfredo Pascual says: ‘With Ilios Sante and The Bloomwell Group, LGP gains access to a new strategic partner in Germany. This aligns with LGP's key growth strategy and solidifies Little Green Pharma's growing presence as one of the leading global medicinal cannabis suppliers.’

Seed holds a 3.1% stake in Little Green Pharma, a medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.

Current stock price: 4.58 pence, down 0.5% in London on Tuesday

12-month change: down 44%

Copyright 2022 Alliance News Limited. All Rights Reserved.